These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2196 related items for PubMed ID: 17545700

  • 1. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F, Mosam A, Henry LN, Chisholm JV, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.
    AIDS; 2007 Jun 19; 21(10):1245-52. PubMed ID: 17545700
    [Abstract] [Full Text] [Related]

  • 2. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
    Bihl F, Berger C, Chisholm JV, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ, Swiss HIV Cohort Study.
    AIDS; 2009 Sep 10; 23(14):1918-22. PubMed ID: 19609199
    [Abstract] [Full Text] [Related]

  • 3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA, Pierrotti LC, Sumita LM, Freire WS, Segurado AA, Pannuti CS.
    J Med Virol; 2007 Oct 10; 79(10):1562-8. PubMed ID: 17705173
    [Abstract] [Full Text] [Related]

  • 4. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM, Calabrò ML, De Rossi A, Aversa SM, Barbierato M, Trevenzoli M, Gasperini P, Zanchetta M, Cadrobbi P, Monfardini S, Chieco-Bianchi L.
    Int J Oncol; 2005 Sep 10; 27(3):779-85. PubMed ID: 16077928
    [Abstract] [Full Text] [Related]

  • 5. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F, de Andrade HF, Fernandes ER, Tuon FF, Brasil RA, Pagliari C, Duarte MI.
    Br J Dermatol; 2008 Sep 10; 159(4):839-46. PubMed ID: 18644020
    [Abstract] [Full Text] [Related]

  • 6. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
    Wilkinson J, Cope A, Gill J, Bourboulia D, Hayes P, Imami N, Kubo T, Marcelin A, Calvez V, Weiss R, Gazzard B, Boshoff C, Gotch F.
    J Virol; 2002 Mar 10; 76(6):2634-40. PubMed ID: 11861829
    [Abstract] [Full Text] [Related]

  • 7. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG, Hirsch HH, Franceschi S, Steffen I, Amari EB, Mueller NJ, Magouras I, Biggar RJ, Rickenbach M, Clifford GM, Swiss HIV Cohort Study.
    AIDS; 2010 Sep 10; 24(14):2245-52. PubMed ID: 20543658
    [Abstract] [Full Text] [Related]

  • 8. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M, Qurishi N, Hoffmann C, Hochdorfer B, Brockmeyer NH, Arasteh K, Mauss S, Rockstroh JK, German Clinical AIDS Working Group (KAAD).
    Infection; 2005 Jun 10; 33(3):140-7. PubMed ID: 15940415
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK, Sprenger HG, Suurmeijer AJ, van der Graaf WT.
    Ned Tijdschr Geneeskd; 2006 Mar 18; 150(11):589-93. PubMed ID: 16610494
    [Abstract] [Full Text] [Related]

  • 17. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V, Caumes E, Gambotti L, Ittah H, Morini JP, Deleuze J, Gorin I, Katlama C, Bricaire F, Dupin N.
    Br J Cancer; 2006 Apr 10; 94(7):1000-6. PubMed ID: 16570046
    [Abstract] [Full Text] [Related]

  • 18. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
    Sirianni MC, Vincenzi L, Topino S, Giovannetti A, Mazzetta F, Libi F, Scaramuzzi D, Andreoni M, Pinter E, Baccarini S, Rezza G, Monini P, Ensoli B.
    Eur J Immunol; 2002 Oct 10; 32(10):2711-20. PubMed ID: 12355422
    [Abstract] [Full Text] [Related]

  • 19. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
    Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ.
    AIDS; 2003 Aug 15; 17(12):1847-51. PubMed ID: 12891072
    [Abstract] [Full Text] [Related]

  • 20. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
    Chang Y, Ziegler J, Wabinga H, Katangole-Mbidde E, Boshoff C, Schulz T, Whitby D, Maddalena D, Jaffe HW, Weiss RA, Moore PS.
    Arch Intern Med; 1996 Jan 22; 156(2):202-4. PubMed ID: 8546554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 110.